What are the recommended oral treatment regimens for central nervous system infections (e.g., bacterial, viral, fungal, tuberculous meningitis) after the patient is clinically stable, has completed an appropriate IV course, and the causative organism is identified?

Home Medications for Central Nervous System Infections

Most CNS infections require completion of the full treatment course with intravenous antibiotics, and true "home oral medications" are limited to specific scenarios: outpatient parenteral antibiotic therapy (OPAT) with IV ceftriaxone for bacterial meningitis, oral fluconazole for cryptococcal meningitis maintenance in HIV patients, and continuation of oral anti-tuberculous therapy after initial IV phase for tuberculous meningitis.

Bacterial Meningitis: Outpatient Parenteral Therapy (OPAT)

The UK guidelines 1 provide the most comprehensive framework for transitioning stable bacterial meningitis patients to home therapy. OPAT with IV ceftriaxone is the primary "home medication" option for bacterial meningitis—not truly oral, but administered at home.

Eligibility Criteria for OPAT

The patient must meet ALL of the following 1:

• Afebrile and clinically improving
• Completed at least 5 days of inpatient IV therapy and monitoring
• Reliable IV access established
• 24-hour access to OPAT team or designated medical care
• No other acute medical needs beyond parenteral antimicrobials
• Patient and family willing to participate

OPAT Regimens by Pathogen

Meningococcal meningitis (N. meningitidis):

• Ceftriaxone 2g IV every 12 hours OR 4g IV once daily (after first 24 hours) 1
• Total duration: 5 days if recovered 1
• Add single dose ciprofloxacin 500mg PO if ceftriaxone not used 1

Pneumococcal meningitis (S. pneumoniae):

• Ceftriaxone 2g IV every 12 hours OR 4g IV once daily (after first 24 hours) 1
• Total duration: 10 days if stable, up to 14 days if slower response 1
• For penicillin/cephalosporin-resistant strains: Ceftriaxone 2g IV every 12 hours PLUS rifampicin 600mg PO every 12 hours 1
• Duration for resistant strains: 14 days 1

H. influenzae meningitis:

• Ceftriaxone 2g IV every 12 hours 1
• Total duration: 10 days 1

Listeria monocytogenes:

• Requires full 21-day IV course; OPAT possible but no oral option 1

Critical OPAT Caveat

Once-daily ceftriaxone should only be used after the first 24 hours of therapy 1. The initial 24 hours require twice-daily dosing to achieve rapid CSF sterilization. Animal studies support once-daily dosing thereafter, but this remains somewhat controversial due to concerns about sub-therapeutic CSF levels 1.

Tuberculous Meningitis: Oral Continuation Therapy

Tuberculous meningitis transitions to oral therapy after the initial phase, making it the most truly "oral home medication" scenario for CNS infections.

Standard Regimen 2, 3

Initial intensive phase (2 months):

• Isoniazid + Rifampin + Pyrazinamide + Ethambutol (all can be oral or IV initially)
• If altered mental status prevents oral intake, use IV formulations of INH, rifampin, aminoglycosides, or fluoroquinolones 2

Continuation phase (7-10 months minimum):

• Isoniazid + Rifampin (oral) for 7-10 additional months 2
• Total treatment duration: Minimum 9-12 months 2, 3
• May extend to 18 months if cultures remain positive or slow clinical response 3

Adjunctive Oral Corticosteroids

Dexamethasone or prednisone should be continued at home during the taper 2, 3:

• Dexamethasone 6-12mg daily OR prednisone 60-80mg daily
• Taper over 4-8 weeks 3
• Recommended for Stage II (confused/focal signs) and Stage III (comatose) patients 2
• Avoid tapering too quickly—CNS inflammation may recur 3

Recent evidence 4 suggests IV steroids can be transitioned to oral after 48 hours of sustained improvement in some patients, though this requires close monitoring.

Cryptococcal Meningitis: Oral Maintenance Therapy

For HIV-infected patients with cryptococcal meningitis, oral fluconazole is the standard maintenance therapy after initial IV treatment 5.

Treatment Phases

Induction phase (not home therapy):

• Amphotericin B 0.7-1 mg/kg/day IV + flucytosine 100 mg/kg/day PO for 2 weeks
• OR amphotericin B + flucytosine for 6-10 weeks 5

Consolidation phase (can be home):

• Fluconazole 400mg PO daily for minimum 10 weeks 5
• May continue for 6-12 months depending on clinical status

Maintenance/suppressive therapy (lifelong home therapy):

• Fluconazole 200-400mg PO daily for life 5
• All HIV-infected individuals should continue maintenance therapy indefinitely (though HAART impact was unclear in 2000 guideline) 5

For isolated pulmonary or urinary cryptococcosis in HIV patients:

• Fluconazole 200-400mg PO daily from the start 5

Alternative for fluconazole intolerance:

• Itraconazole 200-400mg PO daily 5

Viral Meningitis/Encephalitis: Oral Options

Most viral CNS infections have limited oral treatment options:

HSV/VZV encephalitis:

• Requires IV acyclovir during acute phase 6
• No established oral continuation regimen for CNS disease (unlike mucocutaneous HSV)

Lyme neuroborreliosis 7:

• Facial palsy or indolent peripheral neuropathy: Trial of oral doxycycline 100mg PO 2-3 times daily OR amoxicillin 500-1000mg PO three times daily for 21-30 days
• If oral therapy fails: Switch to parenteral ceftriaxone
• Uncomplicated Lyme meningitis: Some data support oral doxycycline, though parenteral therapy is standard

Enterovirus/arbovirus meningitis:

• Supportive care only; no specific antiviral therapy 6

Fungal Meningitis (Non-Cryptococcal): Limited Oral Options

Most fungal CNS infections require prolonged IV amphotericin B 8. Newer azoles may have a role, but data are limited and pathogen-specific. There is no standard oral continuation regimen for most fungal meningitis outside of cryptococcal disease.

Key Clinical Pitfalls

1. Do not assume all bacterial meningitis can transition to oral antibiotics—the evidence supports OPAT with IV ceftriaxone, not oral antibiotics 1.

2. Do not use once-daily ceftriaxone in the first 24 hours—twice-daily dosing is essential for rapid CSF sterilization 1.

3. Do not taper corticosteroids too quickly in tuberculous meningitis—CNS inflammation may recur 3.

4. Do not stop fluconazole maintenance in HIV patients with cryptococcal meningitis—lifelong suppression is recommended 5.

5. Do not confuse "home therapy" with "oral therapy"—most CNS infections requiring home continuation still need IV medications via OPAT 1.

6. Rifampicin can be given orally even during IV ceftriaxone OPAT for resistant pneumococcal meningitis 1, making it a true oral adjunct.